Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
16.07
-0.43 (-2.61%)
At close: Jul 3, 2025, 1:00 PM
16.24
+0.17 (1.06%)
After-hours: Jul 3, 2025, 3:50 PM EDT

Telix Pharmaceuticals Market Cap

Telix Pharmaceuticals has a market cap or net worth of $5.33 billion as of July 3, 2025. Its market cap has increased by 24.02% in one year.

Market Cap
5.33B
Enterprise Value
5.24B
1-Year Change
24.02%
Ranking
Category
Stock Price
16.07

Market Cap Chart

Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $5.33B, an increase of 4,519.71%. That is a compound annual growth rate of 65.20%.

History

DateMarket Cap% Change
Jul 3, 20255.32B4.44%
Dec 31, 20245.10B129.18%
Dec 29, 20232.22B42.30%
Dec 30, 20221.56B-2.70%
Dec 31, 20211.61B96.45%
Dec 31, 2020817.72M196.48%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 701.19B
Johnson & Johnson 373.17B
AbbVie 334.95B
Novo Nordisk 309.43B
UnitedHealth Group 281.50B
Novartis AG 243.28B
Abbott Laboratories 232.29B
AstraZeneca 219.33B
Market Cap Rankings